Search Results
You are looking at 1-1 of 1
Takayuki HojoDDS, PhD,
Yukifumi KimuraDDS, PhD,
Keiji HashimotoDDS,
Takahito TeshirogiDDS, and
Toshiaki FujisawaDDS, PhD
Article Category: Case Report
Volume/Issue: Volume 68: Issue 4
Online Publication Date: Dec 15, 2021
Page Range: 220 – 223
We previously described the case of a patient with primary hypertension managed with telmisartan in which refractory hypotension during general anesthesia was not avoided despite withholding telmisartan for 24 hours before induction. 1 Telmisartan has the longest half-life of angiotensin receptor blockers (ARBs), and in that particular patient's case, withholding telmisartan for 5 days before a second general anesthetic positively resulted in the avoidance of severe refractory hypotension. Azilsartan has the second longest half-life of all